Promising role of defensins peptides as therapeutics to combat against viral infection.

Solanki, Subhash Singh et al.·Microbial pathogenesis·2021·Moderate EvidenceReview
RPEP-05778ReviewModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Review of defensin peptide antiviral mechanisms and therapeutic potential across viral infections

What This Study Found

Defensin peptides have broad-spectrum antiviral activity through direct viral inactivation and immunomodulation, with potential as therapeutic adjuvants against viral infections including COVID-19.

Key Numbers

α, β, θ defensin classes; broad-spectrum antiviral; immunomodulatory and immunoenhancing; potential anti-COVID-19 adjuvant; innate and adaptive immunity stimulation

How They Did This

Review of literature on defensin peptide antiviral mechanisms, applications, and potential as anti-coronavirus therapeutic adjuvants.

Why This Research Matters

Viral pandemics demand rapid therapeutic responses. Defensins, as natural immune components with broad antiviral activity, could supplement vaccines and antiviral drugs as adjuvant therapies.

What This Study Doesn't Tell Us

Review article. Most antiviral defensin data is in vitro. Clinical evidence for defensin-based antiviral therapy is limited. The COVID-19 application is theoretical and not yet tested in trials.

Trust & Context

Original Title:
Promising role of defensins peptides as therapeutics to combat against viral infection.
Published In:
Microbial pathogenesis, 155, 104930 (2021)
Database ID:
RPEP-05778

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-05778·https://rethinkpeptides.com/research/RPEP-05778

APA

Solanki, Subhash Singh; Singh, Parul; Kashyap, Poonam; Sansi, Manish Singh; Ali, Syed Azmal. (2021). Promising role of defensins peptides as therapeutics to combat against viral infection.. Microbial pathogenesis, 155, 104930. https://doi.org/10.1016/j.micpath.2021.104930

MLA

Solanki, Subhash Singh, et al. "Promising role of defensins peptides as therapeutics to combat against viral infection.." Microbial pathogenesis, 2021. https://doi.org/10.1016/j.micpath.2021.104930

RethinkPeptides

RethinkPeptides Research Database. "Promising role of defensins peptides as therapeutics to comb..." RPEP-05778. Retrieved from https://rethinkpeptides.com/research/solanki-2021-promising-role-of-defensins

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.